Atrial Appendage Occluder is an ear shaped pouch present in the top left chamber of the human heart (Left Atrium). The functional significance of this structure is unknown. In patients living with arrhythmic cardiovascular conditions such as atrial fibrillation, blood accumulates in the left atrial appendage and can cause clotting of blood.
Left atrial appendage closure is an implant-based alternative to blood thinners. Like blood thinning medications, an LAAC implant does not cure AF. A stroke can be due to factors not related to a clot traveling to the brain from the left atrium. Other causes of stroke can include high blood pressure and narrowing of the blood vessels to the brain. An LAAC implant will not prevent these other causes of stroke.
In 2019, the market size of Atrial Appendage Occluder is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Atrial Appendage Occluder.
This report studies the global market size of Atrial Appendage Occluder, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Atrial Appendage Occluder sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Boston Scientific
SentreHEART Inc.
Occlutech
AtriCure
Appriva Medical Inc.
St. Jude Medical
PFM Medical Ag.
W. L. Gore & Associates
Cardia, Inc.
Coherex Medical
Market Segment by Product Type
Valvular atrial fibrillation
Non-valvular atrial fibrillation
Market Segment by Application
Clinics
Hospitals
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Atrial Appendage Occluder status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Atrial Appendage Occluder manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Atrial Appendage Occluder are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Atrial Appendage Occluder. Industry analysis & Market Report on Atrial Appendage Occluder is a syndicated market report, published as Global (United States, European Union and China) Atrial Appendage Occluder Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Atrial Appendage Occluder market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.